Creative Medical Technology rises on positive data for stem cell therapy

Creative Medical Technology Holdings

14/02/2025 14:07

** Shares of biotech firm Creative Medical Technology
Holdings  CELZ.O  rise 16.1% to $5.33 premarket
    ** Co says its mid-term follow-up data showed its stem cell
therapy, called StemSpine, was successful in treating chronic
lower back pain and reducing opioid dependency 
    ** Says the study shows significant improvements in pain
levels and functional mobility
    ** Says no serious adverse events were reported
    ** Over 90% of patients reported no opioid use for pain
management three years post-procedure, co says
    ** CELZ rose ~9% in the last 12 months

 (Reporting by Siddhi Mahatole)
 ((siddhiprabhanjan.mahatole@thomsonreuters.com))